Matt Galsky
@MattGalsky
I am a medical oncologist, Director of Genitourinary Medical Oncology @TischCancer and Professor of Medicine @IcahnMountSinai. Views are my own.
ID:724358751285813249
24-04-2016 22:05:59
2,0K Tweets
4,9K Followers
303 Following
The work of Eddy Saad Eli Van Allen Sasha Gusev being highlighted here #ASCO24 ==> we again validate SNP in IL-7 to be associated with irAEs! Dana-Farber Lank Center for Genitourinary Oncology @DanaFarber ASCO #Dana9team OncoAlert
Are you a medical oncologist focused on GU cancers? Join our growing team at Icahn School of Medicine at Mount Sinai The Tisch Cancer Institute
careers.mountsinai.org/jobs/3015097?l…
Molecular testing to guide peri-op management for urothelial cancer
doi.org/10.1200/EDBK_4…
Matt Galsky Pooja Ghatalia ASCO #ASCO24
We collaborated with PeerView for Real Talk on Urothelial Cancer! Join Andrea Necchi, Matt Galsky, Shilpa Gupta & Michiel van der Heijden on 5/31 at 6:30 PM CDT during #ASCO24 in person or online for a #BladderCancer #MedEd event: bit.ly/2024BladderT #Oncology #Urology #MedTwitter
📌Very timely and relevant summary of urothelial cancer management in ASCO #educational book!
doi.org/10.1200/EDBK_4…
#ASCO24 ASCOTECAG ASCOPost ASCOPres Journal of Clinical Oncology OncoAlert Matt Galsky Neeraj Agarwal, MD, FASCO Yüksel Ürün Petros Grivas Shilpa Gupta Enrique Grande #bladder
Ab#4509 ASCO #ASCO24 by Matt Galsky 👉tinyurl.com/5n93ubmm👉GC+NIVO vs. GC in ph 3 Checkmate 901 in pts w/ mUC #bladdercancer 👉Remarkable improvement in PFS & OS w/ GC+NIVO in pts w/ lymph-node only disease 👇Michiel van der Heijden OncoAlert UroToday.com Uromigos Bladder Cancer Advocacy Network
Amazing job by ⭐️ YUO fellow Muneeb Alam at #AACRbladder24 giving podium and poster talks related to data from our phase I trial of intravesical Gemcitabine plus BCG (GemBCG) in BCG-exposed NMIBC #bladdercancer 1/n
please consider opening the GAIN trial at your sites in May 2025!!! DM or email me if interested for more details! Amer. Urol. Assn. Society of Urologic Oncology Bladder Cancer Advocacy Network Rebecca Johnson Stephanie Chisolm, PhD Jonathan Rosenberg MD Matt Galsky Deb Sundi Filipe LF Carvalho Max Kates UroToday.com BackTable Urology
Excited to introduce our new venture OCCAM Immune, offering the immune monitoring capabilities we've built in the Mount Sinai Human Immune Monitoring Center (HIMC) in a streamlined operation for clinical studies by our partners in the Pharma and Biotech industry. More details here >>> occam-immune.com
The 2024 Alliance for Clinical Trials in Oncology Spring Hybrid Group Meeting starts tomorrow (Wednesday, May 15). Have you registered? Take a quick look at the highlights: bit.ly/Alliance-Spr24 #AllianceSpring24 #NCI #NCTN #NCORP #CancerResearch
Alliance for Clinical Trials in Oncology researchers explore innovative approaches to treat pts w/ #bladdercancer . For #NationalBladderCancerAwarenessMonth , we feature five bladder cancer trials currently open for enrollment. Visit: bit.ly/Bladder-Ca #NCI #NCTN #blcsm Bladder Cancer Advocacy Network World Bladder Cancer Patient Coalition
Join us in Chicago or online for the 2024 Alliance Spring Hybrid Group Meeting! Check out a few highlights and be sure to register - bit.ly/Alliance-Spr24 #NCI #NCTN #NCORP #CancerResearch Alliance for Clinical Trials in Oncology
Founded by world-leading immunologists Miriam Merad, MD, PhD, Sacha Gnjatic, Seunghee Kim-Schulze, & Erik Wambre, OCCAM Immune offers biobanking and cutting-edge tools tailored for discovering immune biomarkers for patient stratification and the etiology of immune-mediated diseases.
Congrats to our New York Section AUA Amer. Urol. Assn. leadership class graduates! Vannita 😷Chiang, MD, MBA Reza Mehrazin, MD Doreen E. Chung. We are so proud to have you represent our section!
Thanks to Amer. Urol. Assn. and the mentors for this great opportunity & congratulations to the entire class !
